Novel MRI ANd Biomarkers in GOlimumab-treated Patients With Axial Spondyloarthritis
Status:
Completed
Trial end date:
2017-02-14
Target enrollment:
Participant gender:
Summary
The study investigates different criteria for remission based on MRI and circulating
biomarkers for inflammation, cartilage, connective tissue and bone turnover in patients with
axial spondyloarthritis treated with Golimumab. Furthermore, the study also investigates
factors that affect disease activity, function and participation by use of different
questionnaires.
Details
Lead Sponsor:
Professor Mikkel Østergaard Susanne Juhl Pedersen